个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

The Peritoneal Dialysis Telemedicine-assisted Platform Cohort (PDTAP) Study: Design and methods.

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Ma Tiantian[1,2,3,4] * ; Yang Zhikai[1,2,3,4] ; Li Shaomei[5] ; Pei Huaying[5] ; Zhao Jinghong[6] ; Li Yi[6] ; Xiong Zibo[7] ; Liao Yumei[7] ; Zhao Zhanzheng[8] ; Xiao Jing[8] ; Li Ying[9] ; Lin Qiongzhen[9] ; Zheng Zhaoxia[10] ; Duan Liping[10] ; Fu Gang[11] ; Guo Shanshan[11] ; Hu Wenbo[12] ; Li Yulin[12] ; Sun Fuyun[13] ; Zhao Nan[13] ; Wang Qin[14] ; Ji Tianrong[14] ; Zhang Beiru[15] ; Yu Rui[15] ; Hao Li[16] ; Liu Guiling[16] ; Zuo Li[17] ; Zhao Huiping[17] ; Wang Caili[18] ; Deng Lirong[18] ; Chen Hongyu[19] ; Li Li[19] ; Shen Yulan[20] ; Zhang Yong[20] ; Wang Lihua[21] ; Yan Yan[21] ; Ma Zhigang[22] ; Li Yingping[22] ; Zhang Xianchao[23] ; Wang Xuejian[23] ; Liu Yirong[24] ; Gao Xinying[24] ; Xu Zhonggao[25] ; Zhang Li[25] ; Du Shutong[26] ; Zhao Cui[26] ; Chen Xiaoli[27] ; Li Hongyi[27] ; Yue Yingli[28] ; Chen Shanshan[28] ; Ma Yingchun[29] ; Wei Yuanyuan[29] ; Zhou Jingwei[30] ; Lv Jie[30] ; Zheng Yingdong[31] ; Zhu Sainan[32] ; Zhao Minghui[1,2,3,4] ; the PDTAP Working Group[1] ; Dong Jie[1,2,3,4,*1] ;
机构： [1]Renal Division, Department of Medicine, Peking University FirstHospital, Beijing, China [2]Institute of Nephrology, Peking University, Beijing, China [3]Key Laboratory of Renal Disease, Ministry of Health, Beijing, China [4]Key Laboratory of Renal Disease, Ministry of Education, Beijing, China [5]Renal Division, Department of Medicine, The Second Hospital of HebeiMedical University, Hebei, China [6]Renal Division, Department of Medicine, Xinqiao Hospital of ArmyMedical University, Chongqing, China [7]Renal Division, Department of Medicine, Peking University ShenzhenHospital, Guangdong, China [8]Renal Division, Department of Medicine, The First Affiliated Hospital ofZhengzhou University, Henan, China [9]Renal Division, Department of Medicine, The Third Hospital of HebeiMedical University, Hebei, China [10]Renal Division, Department of Medicine, Handan Central Hospital,Hebei, China [11]Renal Division, Department of Medicine, Peking Haidian Hospital,Beijing, China [12]Renal Division, Department of Medicine, People’s Hospital of QinghaiProvince, Qinghai, China [13]Renal Division, Department of Medicine, Cangzhou Central Hospital,Hebei, China [14]Renal Division, Department of Medicine, The Second Affiliated Hospitalof Harbin Medical University, Heilongjiang, China [15]Department of Nephrology, Shengjing Hospital of China MedicalUniversity, Liaoning, China [16]Renal Division, Department of Medicine, The Second Hospital of AnhuiMedical University, Anhui, China [17]Renal Division, Department of Medicine, Peking University People’sHospital, Beijing, China [18]Renal Division, Department of Medicine, The First Affiliated Hospital ofBaoTou Medical College, Neimenggu, China [19]Renal Division, Department of Medicine, The People’s Hospital ofChuxiong Yi Autonomous Prefecture, Yunnan, China [20]Renal Division, Department of Medicine, Beijing Miyun District Hospital,Beijing, China [21]Renal Division, Department of Medicine, The Second Hospital of ShanxiMedical University, Shanxi, China [22]Renal Division, Department of Medicine, People’s Hospital of Gansu,Gansu, China [23]Renal Division, Department of Medicine, Pingdingshan First People’sHospital, Henan, China [24]Renal Division, Department of Medicine, The First People’s Hospital ofXining, Qinghai, China [25]Renal Division, Department of Medicine, First Hospital of JilinUniversity, Jilin, China [26]Renal Division, Department of Medicine, Cangzhou People’s Hospital,Hebei, China [27]Renal Division, Department of Medicine, Taiyuan Central Hospital,Shanxi, China [28]Renal Division, Department of Medicine, People’s Hospital of Langfang,Hebei, China [29]Renal Division, Department of Medicine, China Rehabilitation ResearchCenter, Beijing Boai Hospital, Beijing, China [30]Renal Division, Department of Medicine, Dongzhimen HospitalAffiliated to Beijing University of Chinese Medicine, Beijing, China [31]Department of Epidemiology and Biostatistics, School of Public Health,Peking University, Beijing, China [32]Department of Statistics, Peking University First Hospital, Beijing,China
出处：
DOI： 10.1177/0896860820962901
ISSN：

摘要：
The primary objective of the Peritoneal Dialysis Telemedicine-assisted Platform Cohort (PDTAP) Study is to explore potential predictors and their effects on patient survival, technique survival, and the occurrence of infectious and noninfectious complications. The PDTAP study is a national-level cohort study in China. A newly developed PD telemedicine application provided a unique and convenient way to collect multicenter, structured data across units. The PDTAP study was underway in 27 hospitals from 14 provinces located at 7 geographical regions (northwest, northeast, north, central, southwest, southeast, and south) in China. Our study aims to enroll at least 7000 adult patients with end-stage renal disease receiving PD. Approval has been obtained through the ethics committees of all hospitals. All participants signed the informed consent form after the center had received ethics board approval in accordance with the Declaration of Helsinki. Patient survival, technique survival, hospitalization, and the occurrence of infectious and noninfectious complications. The PDTAP study aims to explore potential predictors and their effects on patient survival, technique survival, and infectious and noninfectious complications using a newly developed PD telemedicine system to collect multicenter, structured data in real-world practice. Substantial and transformable findings in relation to PD practices were expected. This study also developed a national-level infrastructure for further collaboration and ancillary investigation.

语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2022]版：
大类 | 3 区 医学
小类 | 3 区 泌尿学与肾脏学
最新[2025]版：
大类 | 4 区 医学
小类 | 4 区 泌尿学与肾脏学
JCR分区：
出版当年[2021]版：
Q3 UROLOGY & NEPHROLOGY
最新[2023]版：
Q2 UROLOGY & NEPHROLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者：
第一作者机构： [1]Renal Division, Department of Medicine, Peking University FirstHospital, Beijing, China [2]Institute of Nephrology, Peking University, Beijing, China [3]Key Laboratory of Renal Disease, Ministry of Health, Beijing, China [4]Key Laboratory of Renal Disease, Ministry of Education, Beijing, China
通讯作者：
通讯机构： [1]Renal Division, Department of Medicine, Peking University FirstHospital, Beijing, China [2]Institute of Nephrology, Peking University, Beijing, China [3]Key Laboratory of Renal Disease, Ministry of Health, Beijing, China [4]Key Laboratory of Renal Disease, Ministry of Education, Beijing, China [*1]Renal Division, Institute of Nephrology, Peking University First Hospital, Beijing 100034, China.
推荐引用方式(GB/T 7714)：
Ma Tiantian,Yang Zhikai,Li Shaomei,et al.The Peritoneal Dialysis Telemedicine-assisted Platform Cohort (PDTAP) Study: Design and methods.[J].PERITONEAL DIALYSIS INTERNATIONAL.2022,42(1):75-82.doi:10.1177/0896860820962901.
APA：
Ma Tiantian,Yang Zhikai,Li Shaomei,Pei Huaying,Zhao Jinghong...&Dong Jie.(2022).The Peritoneal Dialysis Telemedicine-assisted Platform Cohort (PDTAP) Study: Design and methods..PERITONEAL DIALYSIS INTERNATIONAL,42,(1)
MLA：
Ma Tiantian,et al."The Peritoneal Dialysis Telemedicine-assisted Platform Cohort (PDTAP) Study: Design and methods.".PERITONEAL DIALYSIS INTERNATIONAL 42..1(2022):75-82

资源点击量：88369 今日访问量：0 总访问量：736 更新日期：2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持：重庆聚合科技有限公司 地址：云南省昆明市西山区金碧路157号